Haplotype markers | poverall | Alleles | Proband | Control | p | ||
---|---|---|---|---|---|---|---|
n | % | n | % | ||||
Only haplotype alleles with an observed frequency >4% in the patients were included in the analysis. | |||||||
*p<0.05, statistically significant. | |||||||
D2S1360–D2S305 | 0.681 | H-2-6 | 5 | 5 | 7 | 3.8 | 0.556 |
H-4-6 | 11 | 11 | 17 | 9.2 | 0.517 | ||
H-4-7 | 5 | 5 | 7 | 3.8 | 0.556 | ||
Other | 79 | 165 | |||||
D2S305–D2S2233 | 0.008* | H-4-7 | 4 | 4 | 7 | 3.8 | 0.854 |
H-6-6 | 5 | 5 | 10 | 5.4 | 0.970 | ||
H-6-7 | 17 | 17 | 12 | 6.5 | 0.003* | ||
H-6-8 | 4 | 4 | 2 | 1.1 | 0.085 | ||
Other | 70 | 165 | |||||
D2S2233–D2S2342 | 0.114 | H-4-2 | 5 | 5 | 12 | 6.5 | 0.695 |
H-6-2 | 9 | 9 | 13 | 7.1 | 0.463 | ||
H-7-2 | 15 | 15 | 18 | 9.8 | 0.133 | ||
H-7-5 | 4 | 4 | 3 | 1.6 | 0.186 | ||
H-7-6 | 8 | 8 | 11 | 6.0 | 0.428 | ||
H-8-6 | 4 | 4 | 3 | 1.6 | 0.186 | ||
H-9-2 | 4 | 4 | 6 | 3.3 | 0.672 | ||
Other | 51 | 130 | |||||
D2S2342–D2S2201 | 0.775 | H-2-8 | 25 | 25 | 42 | 22.8 | 0.487 |
H-2-9 | 5 | 5 | 2 | 1.1 | 0.033* | ||
H-5-8 | 7 | 7 | 18 | 9.8 | 0.523 | ||
H-6-8 | 16 | 16 | 27 | 14.7 | 0.608 | ||
Other | 47 | 107 |